Skip to main content

Table 3 Univariate analysis for OS in younger GBM patients (age < 60 yrs) of TCGA database

From: Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients

Variable

No.(%)

Median OS (months)

P

Median PFS (months)

P

Gender

  

0.002

 

0.131

 Male

78 (57.78)

15.39

 

7.86

 

 Female

57 (42.22)

22.49

 

8.48

 

LANCL2 gene status

  

0.054

 

0.177

 Amplification

33 (24.44)

15.02

 

5.85

 

 No alteration

102 (75.56)

18.08

 

8.48

 

EGFR gene status

  

0.128

 

0.795

 Amplification

56 (41.48)

17.49

 

8.12

 

 No alteration

79 (58.52)

17.79

 

7.63

 

LANCL2 and EGFR genes status

  

0.054

 

0.177

 Co-amplification

33 (24.44)

15.02

 

5.85

 

 No alteration

102 (75.56)

18.08

 

8.48

Â